Dark Antigens® – Novel Tumor-Specific Targets for Cancer Immunotherapy
Time: 9:30 am
day: Day 2
Details:
- Mining the dark genome to uncover regions encoding putative Dark Antigens®
- Integrating large-scale, multiomic data to identify and validate cancer-specific Dark Antigens®
- Characterizing Dark Antigens® with broad therapeutic potential
